Sclerostin — Drug Target

4 drugs 2 marketed 2 in Phase 3

All drugs that target Sclerostin — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Sclerostin inhibitor · Monoclonal antibody

Marketed (2)

Evenity · Amgen · Bone
EVENITY · AMGEN INC · Bone

Phase 3 pipeline (2)

romosozumab HCP administration with PFS · Amgen · Sclerostin inhibitor · Osteoporosis
Romosozumab is a monoclonal antibody that targets sclerostin, a protein that inhibits bone formation.
Romosozumab Prefilled Syringe · Karen Klahr Miller, MD · Monoclonal antibody · Bone disorders
Romosozumab Prefilled Syringe is a monoclonal antibody that targets sclerostin to increase bone formation and decrease bone resorption.